Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma.
about
Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients.
P2860
Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Analysis of adverse events of ...... advanced renal cell carcinoma.
@ast
Analysis of adverse events of ...... advanced renal cell carcinoma.
@en
type
label
Analysis of adverse events of ...... advanced renal cell carcinoma.
@ast
Analysis of adverse events of ...... advanced renal cell carcinoma.
@en
prefLabel
Analysis of adverse events of ...... advanced renal cell carcinoma.
@ast
Analysis of adverse events of ...... advanced renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Analysis of adverse events of ...... advanced renal cell carcinoma.
@en
P2093
Ida Cedrych
Maciej Niemiec
Piotr Skotnicki
P2860
P304
P356
10.5114/AOMS.2016.59262
P577
2016-04-12T00:00:00Z